Related Experiment Videos
Behavioral therapy for childhood constipation: a randomized, controlled trial
Marieke van Dijk1, Marloes E J Bongers, Giel-Jan de Vries
1Psychosocial Department, Emma Children's Hospital, Academic Medical Center, Room G8-224, PO Box 22700, 1100 DE Amsterdam, The Netherlands. m.vandijk@amc.uva.nl
Insights
Behavioral therapy offers no significant advantage over conventional treatment for childhood constipation. However, it may reduce behavior problems in children with constipation.
Area of Science:
- Pediatric Gastroenterology
- Child Psychology
Background:
- Functional constipation is common in children.
- Behavioral interventions are proposed to improve continence in children with functional fecal incontinence associated with constipation.
Purpose of the Study:
- To evaluate the clinical effectiveness of behavioral therapy combined with laxatives compared to conventional treatment for functional constipation in childhood.
Main Methods:
- A randomized controlled trial was conducted with 134 children (aged 4-18 years) over 22 weeks.
- Children were assigned to either behavioral therapy or conventional treatment.
- Primary outcomes included defecation frequency, fecal incontinence frequency, and success rate; secondary outcomes included stool-withholding and behavior problems.
Main Results:
- No significant differences were observed in defecation frequency, fecal incontinence frequency, or success rates between the two groups at the end of treatment or at 6-month follow-up.
- The proportion of children withholding stools did not differ between interventions.
- Behavioral therapy resulted in a significantly smaller proportion of children with behavior problems at follow-up.
Conclusions:
- Behavioral therapy with laxatives shows no superiority over conventional treatment for childhood constipation.
- Behavioral therapy may be beneficial for children with co-existing behavior problems.
Objective:
It has been suggested that the addition of behavioral interventions to laxative therapy improves continence in children with functional fecal incontinence associated with constipation. Our aim was to evaluate the clinical effectiveness of behavioral therapy with laxatives compared with conventional treatment in treating functional constipation in childhood.
Patients And Methods:
In this randomized, controlled trial conducted in a tertiary hospital in The Netherlands, 134 children aged 4 to 18 years with functional constipation were randomly assigned to 22 weeks (12 visits) of either behavioral therapy or conventional treatment. Primary outcomes were defecation frequency, fecal incontinence frequency, and success rate. Success was defined as defecation frequency of > or = 3 times per week and fecal incontinence frequency of < or = 1 times per 2 weeks irrespective of laxative use. Secondary outcomes were stool-withholding behavior and behavior problems. Outcomes were evaluated at the end of treatment and at 6-months follow-up. All of the analyses were done by intention to treat.
Results:
Defecation frequency was significantly higher for conventional treatment. Fecal incontinence frequency showed no difference between treatments. After 22 weeks, success rates did not differ between conventional treatment and behavioral therapy (respectively, 62.3% and 51.5%), nor did it differ at 6 months of follow-up (respectively, 57.3% and 42.3%). The proportion of children withholding stools was not different between interventions. At follow-up, the proportion of children with behavior problems was significantly smaller for behavioral therapy (11.7% vs 29.2%).
Conclusion:
Behavioral therapy with laxatives has no advantage over conventional treatment in treating childhood constipation. However, when behavior problems are present, behavioral therapy or referral to mental health services should be considered.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Irritable Bowel Syndrome III: Medical and Nursing Management